Occudo Quantitative Strategies LP Novo Cure LTD Transaction History

Occudo Quantitative Strategies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $234,352 - $614,540	14,511 New	14,511 $234,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $376,116 - $791,749	6,664 New	6,664 $400,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $883,695 - $1.4 Million	-15,613 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $104,300 - $146,557	-1,734 Reduced 10.0%	15,613 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $284,102 - $461,610	3,784 Added 27.9%	17,347 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $1.58 Million - $2.64 Million	13,563 New	13,563 $1.58 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $320,523 - $554,475	-2,458 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $18,368 - $28,145	148 Added 6.41%	2,458 $325,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $259,089 - $402,263	2,310 New	2,310 $400,000

266

73.8M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.34B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.